In This Article:
In September 2024, the German market has seen modest gains, with the DAX index inching up by 0.11% amid a cautious investor outlook following the U.S. Federal Reserve's interest rate cut. This environment highlights the importance of identifying growth companies with high insider ownership, as these stocks often benefit from strong internal confidence and alignment of interests between management and shareholders. When considering potential investments in this context, it's crucial to focus on companies that demonstrate robust growth potential and have significant insider ownership, which can be indicative of management's belief in their long-term prospects.
Top 10 Growth Companies With High Insider Ownership In Germany
Name | Insider Ownership | Earnings Growth |
pferdewetten.de (XTRA:EMH) | 26.8% | 98.3% |
Stemmer Imaging (XTRA:S9I) | 25.2% | 23.2% |
Deutsche Beteiligungs (XTRA:DBAN) | 39.5% | 54.1% |
Exasol (XTRA:EXL) | 25.3% | 117.1% |
adidas (XTRA:ADS) | 16.6% | 42.1% |
Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
Beyond Frames Entertainment (DB:8WP) | 10.8% | 112.2% |
Redcare Pharmacy (XTRA:RDC) | 17.4% | 51.8% |
elumeo (XTRA:ELB) | 25.8% | 120.2% |
Your Family Entertainment (DB:RTV) | 17.3% | 116.8% |
Underneath we present a selection of stocks filtered out by our screen.
Hypoport
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Hypoport SE develops and markets technology platforms for the financial services, property, and insurance industries in Germany with a market cap of €1.95 billion.
Operations: The company's revenue segments include €157.97 million from the Credit Platform, €66.89 million from the Insurance Platform, and €175.87 million from Segment Adjustment.
Insider Ownership: 35%
Hypoport, a growth company with high insider ownership, has seen its earnings forecast to grow significantly at 34% per year, outpacing the German market. Despite this, its Return on Equity is projected to be low at 9.7%. Recently added to the MDAX Index and removed from the SDAX, Hypoport reported strong Q2 results with sales of €110.62 million and net income of €2.4 million, marking a turnaround from last year's losses.
-
Delve into the full analysis future growth report here for a deeper understanding of Hypoport.
-
The valuation report we've compiled suggests that Hypoport's current price could be inflated.
Redcare Pharmacy
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.51 billion.